Pulocimab
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb) . Pulocimab can be used for the research of cancers[1].
Product Specifications
CAS Number
[2428381-49-9]
Product Name Alternative
AK-109
UNSPSC
12352203
Target
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pulocimab.html
Purity
98.42
Solubility
10 mM in DMSO
Smiles
[Pulocimab]
Molecular Weight
(143.721 kDa)
References & Citations
[1]Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82 (12) :1333-1339.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99808/Pulocimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99808/Pulocimab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
VEGFR2/KDR/Flk-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Anti-CD45 Antibody [2D1], PE-Cy5-25Tests](https://cdn.genprice.uk/genprice/genprice5.png)
MBS1291735-01 0.02 mg (E-Coli)
Recombinant Human Ubiquitin carboxyl-terminal hydrolase 51 (USP51)
Ask
View Details 
MBS1291735-02 0.02 mg (Yeast)
Recombinant Human Ubiquitin carboxyl-terminal hydrolase 51 (USP51)
Ask
View Details MBS1291735-03 0.1 mg (E-Coli)
Recombinant Human Ubiquitin carboxyl-terminal hydrolase 51 (USP51)
Ask
View Details MBS1291735-04 0.1 mg (Yeast)
Recombinant Human Ubiquitin carboxyl-terminal hydrolase 51 (USP51)
Ask
View Details